Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification DOI
Surbhi Sharma, Shweta Dang

Current Neuropharmacology, Journal Year: 2022, Volume and Issue: 21(3), P. 517 - 535

Published: July 7, 2022

Brain disorders are a prevalent and rapidly growing problem in the medical field as they adversely affect quality of life human. With an increase expectancy, it has been reported that diseases like Alzheimer's, Parkinson's, stroke brain tumors, along with neuropsychological disorders, also being at alarmingly high rate. Despite various therapeutic methods for treating drug delivery to challenging because very complex Blood Barrier, which precludes most drugs from entering effective concentrations. Nano-carrier-based systems have widely by researchers overcome this barrier layer. These due their small size, offer numerous advantages; however, short residence time body owing opsonization hinders success vivo. This review article focuses on aspects modifying surfaces these nano-carriers polymers, surfactants, protein, antibodies, cell-penetrating peptides, integrin binding peptides glycoproteins such transferrin & lactoferrin leading enhanced time, desirable characteristics ability cross blood-brain (BBB), increased bioavailability regions targeted delivery.

Language: Английский

Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders DOI
Aline de Alcântara Correia, Ana Rita Monteiro,

RAYANNA BEATRIZ MARQUES DA SILVA

et al.

Advanced Drug Delivery Reviews, Journal Year: 2022, Volume and Issue: 189, P. 114485 - 114485

Published: Aug. 12, 2022

Language: Английский

Citations

100

Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration DOI Creative Commons
Jafar Âkbari, Majid Saeedi, Fatemeh Ahmadi

et al.

Pharmaceutical Development and Technology, Journal Year: 2022, Volume and Issue: 27(5), P. 525 - 544

Published: May 28, 2022

The bioavailability of drugs is dependent on several factors such as solubility and the administration route. A drug with poor aqueous solubility, therefore, poses challenges regards to its pharmaceutical advance ultimately biological usage. Lipid nanoparticles have been used in science due their importance green chemistry. Their biochemical properties ‘green’ materials processes mean they can be environmentally sustainable. Generally, lipid employed carriers for both lipophilic hydrophilic drugs. proposed route present advantages disadvantages which should considered by a formulator. Solid (SLNs) nanostructured (NLCs) are attractive delivery systems because ease manufacture, biocompatibility, biodegradability, scale-up capacity formulation constituents. easy simple scalability novel SLNs nano carriers, along various processing procedures, recent developments, limitation toxicity, optimization approaches manufacture nanoparticles, lyophilization release comprehensively discussed this review. This review also summarizes research data related preparation methods excipients NLCs years.

Language: Английский

Citations

83

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases DOI Creative Commons
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2022, Volume and Issue: 221, P. 112999 - 112999

Published: Nov. 2, 2022

The blood-brain barrier (BBB) restricts the access of therapeutic agents to brain, complicating treatment neurological diseases, such as Alzheimer's disease (AD), Parkinson's (PD), multiple sclerosis (MS), glioma, etc. To overcome this limitation and improve drug delivery central nervous system (CNS), potential nanocarriers, including lipid-based nanosystems, has been explored. Through active targeting, surface nanocarriers can be modified with ligands that interact BBB, enhancing their uptake penetration across brain endothelium by different physiological mechanisms, receptor- or transporter-mediated transcytosis. This review seeks provide an overview targeting in delivery, while highlighting functionalized lipid treat diseases. Therefore, first sections, we discuss importance CNS present commonly used for functionalization, well summarize state art most recent relevant studies surface-modified nanosystems developed disorders. Lastly, challenges hindering clinical translation are discussed, critical insights future perspectives outlined. Although some limitations have identified, it is expected upcoming years these will established approach.

Language: Английский

Citations

75

A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity DOI Creative Commons
Furkan Eker, Hatice Duman, Emir Akdaşçi

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(15), P. 3482 - 3482

Published: July 25, 2024

Nanoparticles are structures that possess unique properties with high surface area-to-volume ratio. Their small size, up to 100 nm, and potential for modifications have enabled their use in a wide range of applications. Various factors influence the applications NPs, including synthesis method physical attributes such as size shape. Additionally, materials used NPs primary determinants application. Based on chosen material, generally classified into three categories: organic, inorganic, carbon-based. These categories include variety materials, proteins, polymers, metal ions, lipids derivatives, magnetic minerals, so on. Each material possesses activity application NPs. Consequently, certain typically particular areas because they higher efficiency along tenable toxicity. Therefore, classification base NP hold significant importance both research In this paper, we discuss these classifications, exemplify most major categorize them according preferred area This review provides an overall application,

Language: Английский

Citations

24

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases DOI Open Access

Linyan Duan,

Xingfan Li,

Rong Ji

et al.

Polymers, Journal Year: 2023, Volume and Issue: 15(9), P. 2196 - 2196

Published: May 5, 2023

Neurodegenerative diseases are common, incurable neurological disorders with high prevalence, and lead to memory, movement, language, intelligence impairments, threatening the lives health of patients worldwide. The blood–brain barrier (BBB), a physiological between central nervous system peripheral blood circulation, plays an important role in maintaining homeostasis intracerebral environment by strictly regulating transport substances brain. Therefore, it is difficult for therapeutic drugs penetrate BBB reach brain, this affects their efficacy. Nanoparticles (NPs) can be used as drug carriers also known nanoparticle-based delivery systems (NDDSs). These not only increase stability but facilitate crossing through improve In article, we provided overview types administration routes NPs, highlighted preclinical clinical studies NDDSs neurodegenerative diseases, summarized combined strategies management diseases. Finally, prospects challenges recent basic research were discussed. Above all, provide inspiring strategy treatment

Language: Английский

Citations

40

Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier DOI Creative Commons
Mohammad Sameer Khan, Sradhanjali Mohapatra,

Vaibhav Gupta

et al.

Membranes, Journal Year: 2023, Volume and Issue: 13(3), P. 343 - 343

Published: March 16, 2023

Over the past few years, pharmaceutical and biomedical areas have made most astounding accomplishments in field of medicine, diagnostics drug delivery. Nanotechnology-based tools played a major role this. The implementation this multifaceted nanotechnology concept encourages advancement innovative strategies materials for improving patient compliance. plausible usage delivery prompts an extension lipid-based nanocarriers with special reference to barriers such as skin blood–brain barrier (BBB) that been discussed given manuscript. limited permeability these two intriguing biological restricts penetration active moieties through brain, resulting futile outcomes several related ailments. Lipid-based provide possible solution problem by facilitating drugs across obstacles, which leads improvements their effectiveness. A emphasis review is placed on composition, mechanism recent applications carriers. It also includes research latest findings form patents clinical trials field. presented data demonstrate capability carriers potential systems (referred topical, dermal transdermal delivery) well can be exploited further development safe efficacious products.

Language: Английский

Citations

26

Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment DOI
Miguel Horta, Paula Soares, Bruno Sarmento

et al.

Drug Delivery and Translational Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 6, 2025

Language: Английский

Citations

1

Research Advances of Lactoferrin in Electrostatic Spinning, Nano Self-Assembly, and Immune and Gut Microbiota Regulation DOI

Ying Li,

Lezhen Dong,

Zhishen Mu

et al.

Journal of Agricultural and Food Chemistry, Journal Year: 2022, Volume and Issue: 70(33), P. 10075 - 10089

Published: Aug. 15, 2022

Lactoferrin (LF) is a naturally present iron-binding globulin with the structural properties of an N-lobe strongly positively charged terminus and cage-like structure nano self-assembly encapsulation. These unique give it potential for development in fields electrostatic spinning, targeted delivery systems, gut-brain axis. This review will provide overview LF's structure, encapsulation, transport capabilities, as well its applications immunity gut microbiota regulation. First, microstructure LF summarized compared homologous ferritin, revealing both functional similarities differences between them. Second, interactions application spinning are summarized. Its positive charge can be applied to environmental protection packaging materials improving drug stability antiviral effects, while promote bone regeneration anti-inflammatory effects. Then behavior exploited protein encapsulate bioactive substances construct systems such contrast agents, antibacterial dressings, anti-cancer therapy, gene delivery. In addition, some covalent noncovalent Maillard reaction other topics briefly discussed. Finally, may affect immunological function via controlling microbiota. conclusion, this paper reviews research advances self-assembly, immune regulation, aiming reference food pharmaceutical fields.

Language: Английский

Citations

29

Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases DOI Open Access
Xavier Llorente, Gerard Esteruelas, Lorena Bonilla

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(9), P. 8053 - 8053

Published: April 29, 2023

Nanocarriers, and especially nanostructured lipid carriers (NLC), represent one of the most effective systems for topical drug administration. NLCs are biodegradable, biocompatible provide a prolonged release. The glutamate release inhibitor Riluzole (RLZ) is currently used amyotrophic lateral sclerosis (ALS), with anti-proliferative effects potentially beneficial diseases excessive cell turnover. However, RLZ possesses low water solubility high light-sensibility. We present here optimized loaded (RLZ-NLCs) as potential treatment. RLZ-NLCs were prepared by hot-pressure homogenization method using active essential oils liquid lipids, design experiments approach. developed obtaining optimal properties dermal application (mean size below 200 nm, negative surface charge entrapment efficacy). In vitro study demonstrates that allow successful delivery in sustained manner. Moreover, not angiogenic able to inhibit keratinocyte proliferation. Hence, system loading combination natural constitutes promising strategy against hyperproliferative conditions.

Language: Английский

Citations

16

Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease DOI

Shalu Singh,

Rahul Shukla

AAPS PharmSciTech, Journal Year: 2023, Volume and Issue: 24(7)

Published: Sept. 2, 2023

Language: Английский

Citations

16